SLYND is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Exeltis Usa, Inc.. The primary component is Drospirenone.
Product ID | 0642-7470_0cdabfc8-f647-42d8-bd85-da6e8a875f24 |
NDC | 0642-7470 |
Product Type | Human Prescription Drug |
Proprietary Name | SLYND |
Generic Name | Drospirenone |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-06-06 |
Marketing Category | NDA / NDA |
Application Number | NDA211367 |
Labeler Name | Exeltis USA, Inc. |
Substance Name | DROSPIRENONE |
Active Ingredient Strength | 4 mg/1 |
Pharm Classes | Progesterone Congeners [CS],Progestin [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-09-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211367 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-01 |
Marketing Category | NDA |
Application Number | NDA211367 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-01 |
Marketing Category | NDA |
Application Number | NDA211367 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-06-06 |
Marketing Category | NDA |
Application Number | NDA211367 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-01 |
Ingredient | Strength |
---|---|
DROSPIRENONE | 4 mg/1 |
SPL SET ID: | db32bc55-f295-4d87-9dbb-0a2f45573dcf |
Manufacturer | |
UNII |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SLYND 88802490 not registered Live/Pending |
Chemo Research, S.L. 2020-02-19 |
SLYND 88274384 not registered Live/Pending |
CHEMO RESEARCH, S.L. 2019-01-24 |